Companies Dominating the Cancer Biomarkers Landscape
- INOVIQ
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bio-Rad Laboratories, Inc.
- Abbott Laboratories
- Becton, Dickinson and Company
- Merck KGaA
- CENTOGENE GmbH
- PerkinElmer Inc.
- Siemens Healthcare GmbH
- F. Hoffmann-La Roche Ltd
- Bristol Myers Squibb Company (BMS)
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Cancer Biomarkers Market in 2025 is assessed at USD 18.68 billion.
The global market size exceeded USD 16.8 billion in 2024 and is set to expand at a CAGR of over 14%, surpassing USD 92.27 billion revenue by 2037.
North America is likely to hit largest share by 2037, fueled by rising population, growing research activities, and increasing health insurance coverage.
The major players in the market include INOVIQ, Bio-Rad Laboratories, Inc., Abbott Laboratories, Becton, Dickinson and Company, Merck KGaA, CENTOGENE GmbH, PerkinElmer Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Bristol Myers Squibb Company (BMS).
